Effects of Safinamide on Pain in Fluctuating Parkinson’s Disease Patients: A Post-Hoc Analysis

Background: Pain, a frequent non-motor symptom in Parkinson’s Disease (PD), significantly impacts on quality of life. Safinamide is a new drug with dopaminergic and non-dopaminergic properties, approved in Europe as adjunct therapy to levodopa for the treatment of fluctuating PD patients. Results fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cattaneo, Carlo, Barone, Paolo, Bonizzoni, Erminio, Sardina, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2017
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302028/
https://www.ncbi.nlm.nih.gov/pubmed/27802242
http://dx.doi.org/10.3233/JPD-160911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302028/
https://www.ncbi.nlm.nih.gov/pubmed/27802242
http://dx.doi.org/10.3233/JPD-160911

Ejemplares similares